Molecular mechanisms of action of bisphosphonates and new insights into their effects outside the skeleton

MJ Rogers, J Mönkkönen, MA Munoz - Bone, 2020 - Elsevier
Bisphosphonates (BP) are a class of calcium-binding drug used to prevent bone resorption
in skeletal disorders such as osteoporosis and metastatic bone disease. They act by …

[HTML][HTML] Systemic autoinflammatory diseases

J Krainer, S Siebenhandl, A Weinhäusel - Journal of autoimmunity, 2020 - Elsevier
Systemic autoinflammatory diseases (SAIDs) are a growing group of disorders caused by a
dysregulation of the innate immune system leading to episodes of systemic inflammation. In …

[HTML][HTML] Canakinumab for the treatment of autoinflammatory recurrent fever syndromes

F De Benedetti, M Gattorno, J Anton… - … England Journal of …, 2018 - Mass Medical Soc
Abstract Background Familial Mediterranean fever, mevalonate kinase deficiency (also
known as the hyperimmunoglobulinemia D syndrome), and the tumor necrosis factor …

The 2021 EULAR/American College of Rheumatology Points to consider for diagnosis, management and monitoring of the Interleukin‐1 mediated autoinflammatory …

M Romano, ZS Arici, D Piskin… - Arthritis & …, 2022 - Wiley Online Library
Background The interleukin‐1 (IL‐1) mediated systemic autoinflammatory diseases,
including the cryopyrin‐associated periodic syndromes (CAPS), tumour necrosis factor …

Molecular mechanisms of phenotypic variability in monogenic autoinflammatory diseases

I Aksentijevich, O Schnappauf - Nature Reviews Rheumatology, 2021 - nature.com
Monogenic autoinflammatory diseases are a group of rheumatologic disorders caused by
dysregulation in the innate immune system. The molecular mechanisms of these disorders …

Cholesterol metabolism: a new molecular switch to control inflammation

D Cardoso, E Perucha - Clinical Science, 2021 - portlandpress.com
The immune system protects the body against harm by inducing inflammation. During the
immune response, cells of the immune system get activated, divided and differentiated in …

The genetics of macrophage activation syndrome

GS Schulert, RQ Cron - Genes & Immunity, 2020 - nature.com
Macrophage activation syndrome (MAS), or secondary hemophagocytic lymphohistiocytosis
(HLH), is a cytokine storm syndrome associated with multi-organ system dysfunction and …

[HTML][HTML] IL-1 inhibitors in the treatment of monogenic periodic fever syndromes: from the past to the future perspectives

H Malcova, Z Strizova, T Milota, I Striz… - Frontiers in …, 2021 - frontiersin.org
Autoinflammatory diseases (AIDs) represent a rare and heterogeneous group of disorders
characterized by recurrent episodes of inflammation and a broad range of clinical …

[HTML][HTML] Potential of IL-1, IL-18 and inflammasome inhibition for the treatment of inflammatory skin diseases

G Fenini, E Contassot, LE French - Frontiers in pharmacology, 2017 - frontiersin.org
In 2002, intracellular protein complexes known as the inflammasomes were discovered and
were shown to have a crucial role in the sensing of intracellular pathogen-and danger …

Periodic fever syndromes

HJ Lachmann - Best practice & research Clinical rheumatology, 2017 - Elsevier
Periodic fever syndromes are autoinflammatory diseases. The majority present in infancy or
childhood and are characterised by recurrent episodes of fever and systemic inflammation …